Viewing Study NCT00826150

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:50 PM
Ignite Modification Date: 2026-06-06 @ 10:31 PM
Study NCT ID: NCT00826150
Status: COMPLETED
Last Update Posted: 2019-06-13
First Post: 2009-01-18
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Phase 1/2a Study of DTA-H19 in Advanced Stage Ovarian Cancer
Sponsor: Anchiano Therapeutics Israel Ltd.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ovarian cancer View
None H19 gene View
None plasmid View
None inodiftagene vixteplasmid View